Sara Sainz de Aja
Corporate Officer/Principal bij Universidad Europea de Madrid SAU
Profiel
Ms. Sara Sainz de Aja is a Manager-Communications & Business Development at Laboratorios Ojer Pharma SL and a Professor at Universidad Europea de Madrid.
Ms. Sainz de Aja was previously employed as a Manager-Institutional Communications by University of Navarra.
She received her graduate degree from The University of Stirling.
Actieve functies van Sara Sainz de Aja
Bedrijven | Functie | Begin |
---|---|---|
Universidad Europea de Madrid SAU | Corporate Officer/Principal | 16-12-2009 |
Eerdere bekende functies van Sara Sainz de Aja
Bedrijven | Functie | Einde |
---|---|---|
University of Navarra | Public Communications Contact | - |
Laboratorios Ojer Pharma SL
Laboratorios Ojer Pharma SL Pharmaceuticals: MajorHealth Technology Laboratorios Ojer Pharma SL develops dermo-pharmaceutical products. Its pipeline encompasses dermatological products that address the treatment and therapeutic needs of skin diseases. The firm’s therapeutic areas cover infections, dermatitis, and ulceration. It also engages in research and development activities, laboratory testing, patent application, and partnerships with academic institutions and research centers. The company was founded on September 19, 2005 by Carlos Gonzalez Ojer and is headquartered in Pamplona, Spain. | Investor Relations Contact | - |
Opleiding van Sara Sainz de Aja
The University of Stirling | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Laboratorios Ojer Pharma SL
Laboratorios Ojer Pharma SL Pharmaceuticals: MajorHealth Technology Laboratorios Ojer Pharma SL develops dermo-pharmaceutical products. Its pipeline encompasses dermatological products that address the treatment and therapeutic needs of skin diseases. The firm’s therapeutic areas cover infections, dermatitis, and ulceration. It also engages in research and development activities, laboratory testing, patent application, and partnerships with academic institutions and research centers. The company was founded on September 19, 2005 by Carlos Gonzalez Ojer and is headquartered in Pamplona, Spain. | Health Technology |